Inventor · disambiguated record
Henry Havel
Also filed as: HAVEL HENRY · HAVEL HENRY A · HAVEL HENRY ACKEN
9 granted patents·4 pending applications·634 citations·filing 1994–2025
91Inventor score
Top patents by PatentIndex Score
13 records- 0195US7144863B2GLP-1 formulations with protracted time actionLILLY CO ELI·Filed 2002·Granted Dec 5, 2006·150 cites·18 claims
- 0295US5547929AInsulin analog formulationsLILLY CO ELI·Filed 1994·Granted Aug 20, 1996·225 cites·15 claims
- 0393US5474978AInsulin analog formulationsLILLY CO ELI·Filed 1994·Granted Dec 12, 1995·174 cites·13 claims
- 0488US7550434B2Stabilized teriparatide solutionsLILLY CO ELI·Filed 2006·Granted Jun 23, 2009·4 cites·34 claims
- 0587US7144861B2Stabilized teriparatide solutionsLILLY CO ELI·Filed 2002·Granted Dec 5, 2006·15 cites·15 claims
- 0686US6770623B1Stabilized teriparatide solutionsLILLY CO ELI·Filed 1998·Granted Aug 3, 2004·57 cites·48 claims
- 0779US11266637B2Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·3 cites·11 claims
- 0871US12246010B2Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2022·Granted Mar 11, 2025·0 cites·15 claims
- 0966US2025205212A1Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1062US2003225000A1Stabilized teriparatide solutionsFiled 2003·Application pending·0 cites
- 1145US2023372294A1Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereofDRACEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1240US2022332676A1Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for intravenous administration and the use thereofDRACEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1337US5663305ASomatotropin analogsUPJOHN CO·Filed 1994·Granted Sep 2, 1997·6 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →